RELAPSED MULTIPLE MYELOMA
Clinical trials for RELAPSED MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for RELAPSED MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat myeloma: bispecific antibody shows promise
Disease control CompletedThis study tested a new drug called REGN5459 in 43 people with multiple myeloma that had returned or stopped responding to other treatments. The drug is a bispecific antibody designed to help the immune system attack cancer cells. The main goals were to check safety and find the …
Matched conditions: RELAPSED MULTIPLE MYELOMA
Phase: PHASE1, PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 05:09 UTC
-
New hope for chinese patients with stubborn myeloma: experimental drug shows promise
Disease control CompletedThis study tested a new medicine, elranatamab, in 39 Chinese adults with multiple myeloma that stopped responding to several standard treatments. The drug works by helping the body's immune system attack the cancer cells. The goal was to see if the drug is safe and can shrink or …
Matched conditions: RELAPSED MULTIPLE MYELOMA
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated May 13, 2026 16:02 UTC